Prana Biotechnology (PRAN)

Add to Watchlists
Create an Alert
3.05 +0.16  +5.54% NASDAQ Apr 27, 16:59 Delayed 2m USD

Prana Biotechnology Total Interest Expense (Quarterly)

View 4,000+ financial data types
View Full Chart

Prana Biotechnology Total Interest Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Prana Biotechnology Historical Total Interest Expense (Quarterly) Data

View and export this data going back to 2008. Start your Free Trial
Export Data Date Range:
Data for this Date Range  

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Interest Expense

When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.

A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.

YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More


PRAN Total Interest Expense (Quarterly) Benchmarks

Genetic Technologies
TBG Diagnostics
Arem Pacific

PRAN Total Interest Expense (Quarterly) Excel Add-In Codes

  • Metric Code: interest_expense
  • Latest data point: =YCP("PRAN", "interest_expense")
  • Last 5 data points: =YCS("PRAN", "interest_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


ADR Top % Movers
MT Newswires 04/24 10:32 ET
ADR Top % Movers
MT Newswires 03/31 10:10 ET
Midday Gainers / Losers
SA Breaking News 03/30 12:45 ET
ADR Top % Movers
MT Newswires 03/30 10:13 ET
Premarket Gainers as of 9:05 am
SA Breaking News 03/30 09:15 ET
FDA OKs Newron's PD med Xadago
SA Breaking News 03/21 16:06 ET

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 7-Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.